Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
Biologics Pricing Report
Oral Solid Dose Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
MilliporeSigma
26 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Process Intensification
Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies
PAO-02-21-CL-03
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
PAO-02021-CL-05
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
PAO-01-21-CL-03
Hot Melt Extrusion
Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion
PAP-Q4-20-CL-016
Extractables & Leachables
Aiding Material Qualification and Risk Assessment for Single-Use Biomanufacturing
PAP-Q4-20-CL-015
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
PAP-Q4-20-CL-014
Gene Therapy
Anticipating the Next Decade of Gene Therapy
PAO-11-20-CL-02
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
PAO-10-20-CL-03
Wet Granulation
The Application of Mannitol In Wet Granulation
PAO-10-20-CL-01
Lipid Excipients
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
PAP-Q3-20-CL-024
Clinical Trials
Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA
PR-M09-20-32
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
PR-M09-20-NI-14
Capacity Expansion
MilliporeSigma Invests $20 Million in New Switzerland Laboratory
PR-M07-20-NI-022
Depth Filtration
Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration
PAP-Q2-20-CL-030
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
PR-M04-20-NI-032
Purification
High-Productivity Membrane Chromatography to Enable Next-Generation Purification of Monoclonal Antibodies
PAP-Q4-19-CL-023
Biopharma
Bioprocess of the Future: What’s In it for Biomanufacturers?
PAP-Q2-2019-CL-026
M Lab
MilliporeSigma Opens First M Lab™ Collaboration Center in Europe
PR-M03-19-NI-060
CRISPR
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M03-19-NI-009
Awards
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
PR-M11-18-NI-101
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
CRISPR
MilliporeSigma Receives Two More Patents for CRISPR Technology
PR-M02-18-NI-86
BioLife Solutions Executes OEM Agreement with MilliporeSigma
PR-M02-18-NI-57
Innovation
MilliporeSigma Expands Celonic's Upstream Capabilities with Mobius® Single-use Bioreactors
PR-M09-17-NI-004
1
2
»
